Comparison of eptifibatide and abciximab in the in-hospital outcomes and thrombocytopenia during percutaneous coronary intervention

被引：0
|
作者：
Suleiman, M [1 ]
Gruberg, L [1 ]
Halabi, M [1 ]
Nikolsky, E [1 ]
Grenadier, E [1 ]
Boulus, M [1 ]
Markiewicz, W [1 ]
Beyar, R [1 ]
机构：
[1] Rambam Med Ctr, Dept Cardiol, Haifa, Israel
来源：
EUROPEAN HEART JOURNAL | 2002年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：434 / 434
页数：1
相关论文
共 50 条
  • [41] Meta-analysis of effectiveness and safety of abciximab versus eptifibatide or tirofiban in percutaneous coronary intervention
    Brown, DL
    Fann, CSJ
    Chang, CJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (05): : 537 - 541
  • [42] Hospital Percutaneous Coronary Intervention Appropriateness and In-Hospital Procedural Outcomes Insights From the NCDR
    Bradley, Steven M.
    Chan, Paul S.
    Spertus, John A.
    Kennedy, Kevin F.
    Douglas, Pamela S.
    Patel, Manesh R.
    Anderson, H. Vernon
    Ting, Henry H.
    Rumsfeld, John S.
    Nallamothu, Brahmajee K.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (03): : 290 - 297
  • [43] Prognostic Significance of In-hospital Acquired Thrombocytopenia in Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    Jiang, Ping
    Gao, Zhan
    Zhao, Wei
    Song, Ying
    Tang, Xiaofang
    Xu, Jingjing
    Wang, Huanhuan
    Jiang, Lin
    Chen, Jue
    Qiao, Shubin
    Yang, Yuejin
    Gao, Runlin
    Xu, Bo
    Yuan, Jinqing
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 358 (01): : 19 - 25
  • [44] Overview of glycoprotein IIb/IIIa clinical trials with abciximab and eptifibatide in acute coronary syndromes and percutaneous coronary intervention
    Teirstein, P
    JOURNAL OF INVASIVE CARDIOLOGY, 1999, 11 : 26C - 30C
  • [45] Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
    Doustkami, Hossein
    Ahari, Saeed Sadeghieh
    Jam, Effat Irani
    Habibzadeh, Afshin
    CARDIOLOGY RESEARCH, 2018, 9 (02) : 107 - 110
  • [46] Immediate and In-hospital Complications of Percutaneous Coronary Intervention
    Rahman, Md. Toufiqur
    Majumder, A. A. S.
    Rahman, Afzalur
    Ali, Mahboob
    Chowdhury, Abdul Wadud
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 17 (0E) : 8 - 8
  • [47] IMMEDIATE AND IN-HOSPITAL COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION
    Rahman, T.
    Rahman, A.
    Majumder, A.
    ATHEROSCLEROSIS, 2015, 241 (01) : E213 - E213
  • [48] A comparison of total hospital costs for percutaneous coronary intervention patients receiving abciximab versus tirofiban
    McCollam, PL
    Lage, MJ
    Bala, M
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2001, 54 (02) : 152 - 157
  • [49] A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions
    Long, Kirsten H.
    Ting, Henry H.
    McMurtry, Erin K.
    Lennon, Ryan J.
    Wood, Douglas L.
    Holmes, David R., Jr.
    Raveendran, Ganesh
    Rihal, Charanjit S.
    VALUE IN HEALTH, 2008, 11 (03) : 462 - 469
  • [50] Comparison of Abciximab Versus Eptifibatide During Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (from the HORIZONS-AMI Trial)
    Singh, Harsimran S.
    Dangas, George D.
    Guagliumi, Giulio
    Yu, Jennifer
    Witzenbichler, Bernhard
    Kornowski, Ran
    Grines, Cindy
    Gersh, Bernard
    Dudek, Darius
    Mehran, Roxana
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (07): : 940 - 947
12345